These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 31932263)
1. Quantitative assessment of CD68+ AND CD163+ macrophages in the primary focus and metastatic lesions of regional lymph nodes in non-luminal her2-positive invasive breast carcinoma. Aikian AZ; Shynkevych VI; Kaidashev IP Wiad Lek; 2019 Oct; 72(10):1861-1865. PubMed ID: 31932263 [TBL] [Abstract][Full Text] [Related]
2. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. Medrek C; Pontén F; Jirström K; Leandersson K BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040 [TBL] [Abstract][Full Text] [Related]
3. CD68+, but not stabilin-1+ tumor associated macrophages in gaps of ductal tumor structures negatively correlate with the lymphatic metastasis in human breast cancer. Buldakov M; Zavyalova M; Krakhmal N; Telegina N; Vtorushin S; Mitrofanova I; Riabov V; Yin S; Song B; Cherdyntseva N; Kzhyshkowska J Immunobiology; 2017 Jan; 222(1):31-38. PubMed ID: 26391151 [TBL] [Abstract][Full Text] [Related]
4. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma. Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry. Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162 [TBL] [Abstract][Full Text] [Related]
6. Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis. Zwager MC; Bense R; Waaijer S; Qiu SQ; Timmer-Bosscha H; de Vries EGE; Schröder CP; van der Vegt B Breast Cancer Res Treat; 2023 Feb; 198(1):11-22. PubMed ID: 36622544 [TBL] [Abstract][Full Text] [Related]
7. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers. Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648 [TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer. Klingen TA; Chen Y; Aas H; Wik E; Akslen LA Hum Pathol; 2017 Nov; 69():72-80. PubMed ID: 28923419 [TBL] [Abstract][Full Text] [Related]
9. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role. Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622 [TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages (TAMs): clinical-pathological parameters in squamous cell carcinomas of the lower lip. Lúcio PS; Ribeiro DC; Aguiar MC; Alves PM; Nonaka CF; Godoy GP Braz Oral Res; 2016 Aug; 30(1):e95. PubMed ID: 27556682 [TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages in human breast cancer parenchyma negatively correlate with lymphatic metastasis after neoadjuvant chemotherapy. Mitrofanova I; Zavyalova M; Telegina N; Buldakov M; Riabov V; Cherdyntseva N; Kzhyshkowska J Immunobiology; 2017 Jan; 222(1):101-109. PubMed ID: 27510849 [TBL] [Abstract][Full Text] [Related]
12. High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer. Jääskeläinen MM; Tumelius R; Hämäläinen K; Rilla K; Oikari S; Rönkä A; Selander T; Mannermaa A; Tiainen S; Auvinen P Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339385 [TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical evaluation of tumor-associated macrophages (M1 and M2) in carcinoma prostate - An institutional study. Hadimani SM; Das S; Harish KG J Cancer Res Ther; 2023 Apr; 19(Supplement):S300-S305. PubMed ID: 37148007 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical characterization and morphometric analysis of macrophages in rat mammary tumors. Ong CB; Brandenberger C; Kiupel M; Kariagina A; Langohr IM Vet Pathol; 2015 Mar; 52(2):414-8. PubMed ID: 24842486 [TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages and crown-like structures in adipose tissue in breast cancer. Cha YJ; Kim ES; Koo JS Breast Cancer Res Treat; 2018 Jul; 170(1):15-25. PubMed ID: 29468486 [TBL] [Abstract][Full Text] [Related]
16. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure. Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833 [TBL] [Abstract][Full Text] [Related]
17. CD163-Positive Macrophages Within the Tumor Stroma Are Associated With Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma. Yamagata Y; Tomioka H; Sakamoto K; Sato K; Harada H; Ikeda T; Kayamori K J Oral Maxillofac Surg; 2017 Oct; 75(10):2144-2153. PubMed ID: 28399391 [TBL] [Abstract][Full Text] [Related]
18. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma. Mwafy SE; El-Guindy DM J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332 [TBL] [Abstract][Full Text] [Related]
19. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476 [TBL] [Abstract][Full Text] [Related]
20. Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression. Inagaki K; Kunisho S; Takigawa H; Yuge R; Oka S; Tanaka S; Shimamoto F; Chayama K; Kitadai Y Cancer Sci; 2021 Jul; 112(7):2692-2704. PubMed ID: 33964093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]